Exact Sciences
Exact Sciences Corporation is a molecular diagnostics company based in Madison, Wisconsin, specializing in cancer screening and diagnostic tests. The company is best known for Cologuard, a non-invasive stool-based DNA test designed to detect colorectal cancer and pre-cancer, which is endorsed by leading cancer screening guidelines. Additionally, Exact Sciences offers Oncotype DX, a suite of gene expression tests that assess the recurrence risk and treatment benefits for breast and colon cancers, as well as the Oncotype DX AR-V7 Nucleus Detect test for advanced stage prostate cancer. Exact Sciences is committed to advancing its technology through research and development, focusing on enhancing the performance of Cologuard and exploring blood or fluid-based tests. The company holds exclusive intellectual property for its screening technology and has established partnerships with organizations such as the Mayo Foundation for Medical Education and Research.
Viomics
Acquisition in 2020
Viomics Inc. is a molecular diagnostic company based in Phoenix, Arizona, founded in 2012 and operating as a subsidiary of Exact Sciences Corporation. The company specializes in cancer detection technologies, focusing on the early identification of lung cancer through non-invasive blood tests. Viomics offers advanced sequencing capabilities and expertise in recognizing unique biomarkers associated with cancer in solid tissues and blood. By utilizing targeted RNA screening and detection of specific markers, Viomics aims to facilitate real-time monitoring of tumor events, thereby enabling timely and targeted therapeutic interventions for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.